A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

To join this study, you would need to have certain types of lung cancer or a specific type of liver cancer for which Atezolizumab is already an approved treatment by the NHS. Your doctor would confirm if your cancer type fits these requirements, such as whether it's early or advanced stage, and if you haven't received other specific treatments recently that would prevent you from taking part.

You would not be able to join if you are already taking Atezolizumab as part of another research study, or if you are receiving other cancer treatments at the very same time. The study also needs to make sure you are getting Atezolizumab in the usual way that doctors prescribe it. Importantly, you must be willing to fill out questionnaires about how you feel and your satisfaction with the treatment.

If you join this study, you won't be given a new or different treatment. You will continue to receive Atezolizumab as your doctor has already prescribed it for your cancer, following the standard care you would normally receive. The main part of your participation will involve completing questionnaires regularly. These questionnaires will ask about your satisfaction with the treatment, your general health, and how the treatment affects your daily life. The study will also collect information from your existing medical records about how your treatment is progressing and any side effects you might experience. There will be no extra visits or tests specifically for this study outside of your usual appointments.